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Abstract
Following repeated encounters with adenoviruses most of us develop robust humoral and
cellular immune responses that are thought to act together to combat ongoing and subse-
quent infections. Yet in spite of robust immune responses, adenoviruses establish subclini-
cal persistent infections that can last for decades. While adenovirus persistence pose
minimal risk in B-cell compromised individuals, if T-cell immunity is severely compromised
reactivation of latent adenoviruses can be life threatening. This dichotomy led us to ask how
anti-adenovirus antibodies influence adenovirus T-cell immunity. Using primary human
blood cells, transcriptome and secretome profiling, and pharmacological, biochemical,
genetic, molecular, and cell biological approaches, we initially found that healthy adults har-
bor adenovirus-specific regulatory T cells (Tregs). As peripherally induced Tregs are gener-
ated by tolerogenic dendritic cells (DCs), we then addressed how tolerogenic DCs could be
created. Here, we demonstrate that DCs that take up immunoglobulin-complexed (IC)-ade-
noviruses create an environment that causes bystander DCs to become tolerogenic. These
adenovirus antigen loaded tolerogenic DCs can drive naïve T cells to mature into adenovi-
rus-specific Tregs. Our study reveals a mechanism by which an antiviral humoral responses
could, counterintuitively, favor virus persistence.
Author summary
While numerous studies have addressed the cellular and humoral response to primary
virus encounters, relatively little is known about the interplay between persistent infec-
tions, neutralizing antibodies, antigen-presenting cells, and T-cell responses. Our studies
suggests that if adenovirus–antibody complexes are taken up by professional antigen-pre-
senting cells (e.g. dendritic cells), the DCs can generate an environment that causes
bystander dendritic cells to become tolerogenic. These tolerogenic dendritic cells favors
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Introduction
Human adenoviruses (HAdVs), of which there may be 85 types (based on serology and
genome analyses), typically cause self-limiting respiratory, ocular, and gastro-intestinal tract
infections in immunocompetent individuals. After repeated encounters, most young adults
generally harbor cross-reactive, long-lived humoral and T-cell responses [1–3] that are thought
to work together to efficiently blunt subsequent HAdV-induced morbidity. However, in spite
of the robust anti-HAdV immune responses, HAdVs routinely establish decades-long, subclin-
ical infections that are characterized by low level shedding of progeny virions [4,5]. While
potential molecular mechanisms by which HAdVs evade the immune response have been pro-
posed [6], we suspected that complementary mechanisms also exist. Of note, in T-cell compro-
mised patients the loss of cellular control of persistent HAdV infection can lead to fulminant
and fatal disease [4,5]. It is noteworthy that serological evidence that the patient has been
infected by a given HAdV type before hematopoietic stem cell transplantation is predictive of
escape from the same HAdV type during immune suppression [7].
While T-cell therapy has shown a notable potential to prevent HAdV disease in immuno-
compromised patients [8,9], immunoglobulin therapy has had remarkably little impact [4].
Due to omnipresent anti-HAdV antibodies, it is not surprising that immunoglobulin-com-
plexed HAdVs (IC-HAdVs) are detected in some patients with HAdV disease [10–12]. In a
broader view, immunoglobulin-complexed viruses can form during prolonged viremia, sec-
ondary infections, primary infections when a cross-reactive humoral response exists, and in
the presence of antibody-based antiviral therapy. It is important to note that IC-HAdVs are
potent stimulators of human dendritic cell (DC) maturation [13,14]. In immunologically naïve
hosts, immunoglobulin-complexed antigens are efficient stimulators of antibody and cytotoxic
T-cell responses [15]. However, most studies using immunoglobulin-complexed antigens have
used prototype antigens that have little impact on their intracellular processing. This is not the
case for IC-HAdVs. The endosomolytic activity of protein VI, an internal capsid protein, pre-
vents the canonical processing of the IC-HAdVs by enabling the escape of HAdV capsid and
its genome from endosomes into the cytoplasm [14]. In the cytoplasm, the HAdV genomes are
detected by absent in melanoma 2 (AIM2), a cytosolic pattern recognition receptor (PRR)
[16]. AIM2 engagement of the 36 kb HAdV-C5 genome induces pyroptosis, a pro-inflamma-
tory cell death in conventional DCs [17]. Pyroptosis entails inflammasome formation, caspase
1 recruitment/auto-cleavage/activation, pro-IL-1β processing, gasdermin D (GSDMD) cleav-
age, GSDMD-mediated loss of cell membrane integrity, and IL-1β release [18,19].
Just as immune responses need to be initiated, suppression of cellular responses are primor-
dial to avoid excessive tissue damage and feature prominently in acute and chronic infection
[20–22]. Control of antigen-specific T cells can be mediated in part by peripherally induced
antigen-specific regulatory T cells (Tregs) [23], which can favor the establishment of persistent
viral infections. Moreover, tolerogenic DCs are required for antigen-specific Treg formation.
The variable phenotype and functionality of tolerogenic DCs are globally characterized by a
semi-mature profile encompassing cell surface costimulatory molecules, cytokine expression
and secretion, and antigen uptake and processing [24,25].
The goals of our studies were to determine how anti-HAdV humoral immunity impacts the
cellular response to HAdVs, and whether this might affect persistence. Initially, we found that
IgG-complexed adenovirus and tolerance
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healthy adults harbor HAdV-specific Tregs. We then demonstrated that IC-HAdV5-challenged
human DCs induce a tolerogenic phenotype in bystander DCs. We show that the bystander
DCs are capable of taking up and presenting HAdV antigens, and can drive naïve T cells to
mature into HAdV-specific Tregs. Our study reveals a mechanism by which an antiviral
humoral responses could, counterintuitively, favor virus persistence.
Results
HAdV-specific Tregs in healthy donors dampen HAdV-specific T cell
proliferation
Initially, we asked if healthy adults harbor HAdV-specific Tregs and if so, are they capable of
dampening anti-HAdV T-cell proliferation. To address these questions, we pre-screened a
cohort of healthy individuals using an IFN-γ ELISpot assay for a memory T-cell response to
HAdVs using a pool of overlapping HAdV5 hexon peptides (hexon is the major protein in the
HAdV capsid). It is important to note that the anti-HAdV T-cell response is not species—or
type-specific as the hexon sequence is highly conserved among all HAdVs. While the majority
of 58 donors in this assay had a HAdV-specific T-cell response, PBMCs from 11 individuals
with a spot forming unit ratio 5-fold greater than mock-treated cells were selected for further
analyses. Because inducible Tregs can produce IL-10 in response to their cognate antigen, the
ability of HAdV-specific CD4+ T cells to produce IL-10 as well as IFN-γ, TNF, and IL-2 was
assessed by multi-parametric flow cytometry. Consistent with our previous results [13], the
cytokine profile of HAdV-specific memory CD4+ T cells was dominated by polyfunctional
IFN-γ+/IL-2+/TNF+/IL-10- cells (approximately 25% of total HAdV-specific CD4+ T cells) and
IFN-γ+/IL-2-/TNF-/IL-10- cells (approximately 20%) (Fig 1A, a representative donor). We
then characterized the combinations of the responses and the percentage of functionally dis-
tinct populations in all donors (Fig 1B). Each slice of the pie chart corresponds to HAdV-spe-
cific CD4+ T cells with a given number of functions, within the responding T-cell population.
Of note, IL-10-producing HAdV-specific CD4+ T cells, which were approximately 5% of total,
were predominantly IFN-γ-/IL-2-/TNF-. To determine if the IL-10 producing T cells have a
Treg phenotype, the expression of conventional Treg markers, CD45RO, CD25, FoxP3, and
CD127 [26], were assessed. We found that approximately 8% of the IL-10 producing T cells
were CD25+/FoxP3+/CD127dim. By contrast, most of IFN-γ producing HAdV-specific CD4+ T
cells harbored a conventional memory phenotype (CD45RO+/FoxP3-/CD25-/CD127+) (Fig
1C). These data demonstrate the presence of HAdV-specific Tregs in healthy adults.
To determine if putative HAdV-specific Tregs have regulatory functions, we used PBMCs
from 5 individuals that harbored an anti-HAdV T-cell response. The CFSE-labeled PBMCs, or
CFSE-labeled PBMCs depleted in CD25-expressing cells, were incubated with HAdV5 or the
hexon peptide pool and T-cell proliferation was quantified. We found that depletion of CD25+
cells caused CD4+ cells to proliferate greater than control peptide-challenged CD4+ cells (Fig
1D), suggesting that the HAdV-specific Tregs in the CD25
+ population can restrict the prolifer-
ative anti-HAdV T cells. Taken together, these data indicate that a fraction of HAdV-specific
CD4+ T cells harbors an inducible Treg phenotype, and that healthy adults likely have CD25
+
Tregs that dampen the proliferation of HAdV-specific T cells.
Phenotypic maturation of bystander DCs
A prerequisite for antigen-specific Treg formation is the presence of antigen-presenting tolero-
genic DCs [27,28]. Because the cellular profile of HAdV5-challenged DC [29] is inconsistent
with that of tolerogenic DCs [29], we asked if IC-HAdV5 could be involved in the generation
IgG-complexed adenovirus and tolerance
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of HAdV-presenting tolerogenic DCs. When HAdV5 is mixed with neutralizing antibodies
from human sera, 200 nm-diameter complexes are formed that induce DCs to undergo pyropto-
sis, or, if the DC does not die, a hypermature profile [13,14]. As these profiles are also inconsis-
tent with that of tolerogenic DCs, we hypothesized that it was not due to IC-HAdV5-activated
DCs, but rather an effect on bystander DCs.
To assess the impact of IC-HAdV5-induced pyroptosis and DC maturation on bystander
DCs we developed a transwell assay (see S1A Fig for schematic). Briefly, CD14+ monocytes
isolated from fresh buffy coats were induced to differentiate into immature DCs for 6 days.
Immature DCs seeded in 12-well plates were mock-treated, challenged with bacterial lipopoly-
saccharides (LPS) as a generic control for DC reactivity, HAdV5, IgGs, or IC-HAdV5 (these
cells will be referred to “direct DCs”). At 6 h post-challenge, a transwell insert was added and
naive immature DCs (bystander DCs) from the same donor were seeded in the upper chamber
(see S1B–S1D Fig for controls concerning transfer of HAdV5 particles between chambers and
cell death). Twelve hours after adding the bystander DCs to the upper chamber, the direct and
bystander DCs were collected and assayed as described below. Compared to bystander DCs
stimulated by direct DCs challenged with IgG or HAdV5, bystander DCs stimulated by
IC-HAdV5-challenged DCs increased their cell surface levels of the maturation/activation
markers CD80, CD83, CD86 (Fig 2A), CD40, and MHC II (S2A Fig). The level of CD86 on
bystander DCs tended to increase as the number of IC-HAdV5 particles increased during the
stimulation of the direct DCs (S2B Fig). The cell surface increase of CD86 and CD83 was also
accompanied by an increase in total (cell surface + intracellular) CD86 and CD83 levels (Fig
2B). Together, these data demonstrate that IC-HAdV5-challenged DCs enhanced the synthesis
and cell surface expression of maturation/activation markers on bystander DCs.
The cytokine transcriptome of bystander DCs suggests a tolerogenic profile
To characterize bystander DC functional capabilities we used an 84-plex inflammatory cyto-
kine, chemokine and their receptor mRNA array to quantify transcriptional changes (see S2C
Fig for the list of mRNAs that gave unique amplification profiles). Stimulation of bystander
DCs with the milieu from HAdV5-challenged DCs (without IgGs) led to notable increases
(>50 fold) in mRNA levels of Th1/Th17 cell activation/differentiation markers (e.g. CXCL9,
CXC10 & CXC11) (see S2C Fig for all data and Fig 3A left hand columns for selected data). By
contrast, the bystander DC response to the IC-HAdV5-challenged DCs was greater with
respect to the number of mRNAs altered (>20) and magnitude (up to 10,000-fold increase)
(Fig 3A right column, and S2C Fig middle column). Of particular relevance was the lack of
TNF mRNA by bystander DC because tolerogenic DCs should not, a priori, secrete TNF. To
better understand the transcriptional responses of the different conditions, we applied a prin-
cipal component analysis (PCA) to find patterns in these data sets. We found that two princi-
pal components (see Materials & Methods for genes in the F1, F2, and F3 axes) explained 89%
Fig 1. HAdV-specific Tregs are present in normal healthy adults. A) Representative flow cytometry profile of hexon peptides- and HAdV5-specific (bottom
left and right panels) CD4 T cells producing TNF, IL-2, IFN-γ, and IL-10 in a representative subject. Top left panel: mock stimulated (negative control). Top
right panel: cytokine profiles of CD4 T cells stimulated with SEB (Staphylococcal enterotoxin B, positive control). B) Cumulative (n = 11 donors) cytokine
profiles of hexon peptides (blue points) and HAdV5 (red points) CD4 T cells producing TNF, IL-2, IFN-γ, and IL-10. All possible combinations of responses
are shown on the x-axis, and the percentage of functionally distinct cell populations within the CD4 T-cell populations are shown on the y-axis. Responses are
grouped and color-coded on the basis of the number of functions. The pie chart summarizes the data, and each slice corresponds to the fraction of CD4 T cells
with a given number of functions, within the responding CD4 T cells. Red arcs correspond to IL-10 producing CD4 T cell. C) Proportion of IL-10 or IFN-γ-
producing HAdV5-specific CD4 T cells expressing CD25 and FoxP3 among IL-10, or IFN-γ, producing HAdV5-specific CD4 T cells. D) Proliferation of
CFSE-labeled PBMCs and PBMCs depleted in CD25+ cells (ΔCD25) activated by HAdV5 (red lines) or hexon peptides (blue lines) and cultured for 7 days.
The cells were analyzed by flow cytometry for proliferation (CFSElow) and CD4 using FlowJo software (n = 6 donors and assayed in duplicate).
https://doi.org/10.1371/journal.ppat.1007127.g001
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and 39% of the total information, respectively, and each stimulus is distinguishable from the
others (Fig 3B).
Because a cell infected by one HAdV particle could produce >104 virions ~36 h later, local
and global HAdV levels, as well as IC-HAdV formation, are dynamic at early stages of infec-
tion. Of note, IC-HAdV5 causes a dose-dependent induction of pyroptosis in direct DCs [14].
We therefore extended the mRNA array analyses by quantifying dose-dependent response of
bystander DCs. Using RT-qPCR we analyzed TNF, IFNβ and CXCL10 (Fig 3C) and IL1β, IL12
(p40), CCL3 and IL6 (S2D Fig) mRNA levels. In all cases the transcriptional response of
bystander DCs varied depending on the IC-HAdV5 challenge dose. These data suggest that
the bystander DC response is linked to the percentage of direct DCs undergoing pyroptosis
[14].
To characterize time-dependent transcriptional changes in direct DC and bystander DCs,
we compared mRNA levels of TNF, IFNβ (Fig 3D), Mip-1α and IL6 (S3 Fig, which also
includes dose-dependent response). Globally, mRNAs that code for pro-inflammatory mole-
cules were 2 to 10-fold greater in direct DCs than in bystander DCs. In addition, only IL1β and
Mip1α mRNA levels changed significantly (p< 0.01) over time. These data demonstrate that
bystander DCs have a semi-mature transcriptional profile, which is linked to DC pyroptosis,
and lack noteworthy levels of TNF mRNA [30].
Cytokine secretion by bystander DCs is consistent with a tolerogenic
profile
To examine the events downstream the transcriptional response, we quantified the secreted
cytokine from direct and bystander DCs. Because proteins can readily diffuse across the trans-
well membranes, bystander DCs were removed from the upper chamber 12 h post-challenge,
rinsed, and then placed in a separate well with fresh medium for 9 h before collecting the
medium. The direct DC medium was collected at 12 h post-challenge, or after a wash at 12 h
and then collected 9 h later (21 h) to compare conditions similar to that used for bystander
DCs (see Fig 4A for schematic). Challenging DCs with HAdV5 alone had a modest effect on
their secretome with the exception of a 5- to 10-fold increase in TNFSF10, and CXCL9 & 10
levels (Fig 4B, second column from the left). By contrast, IC-HAdV5-challenged DCs
responded with increases of>15 fold in approximately half of the cytokines (Fig 4B, middle
columns). These data are consistent with previous results showing the robust maturation of
IC-HAdV5-challenged DCs [13,14]. HAdV5-challenge DCs that were rinsed 12 h post-stimu-
lation had overall lower cytokine levels than prior to washing, but TNFSF10, CXCL9,
CXCL11, and CCL5 levels remained robust (Fig 4C, middle columns). Interestingly, instead of
a positive correlation between the cytokine secretion and the IC-HAdV5 dose, we found that
as the IC-HAdV5 dose increased, the cytokines secreted by direct DCs tended to decrease (Fig
4C, middle columns).
Using HAdV5-challenged DCs (without IgGs) to generate bystander DCs, we found that
the latter secreted 3- to 12-fold higher levels of TNFSF10, CCL5, CXCL9, CXCL10 and
CXCL11 compared to bystander DCs exposed to the medium from IgG-challenged DCs (Fig
Fig 2. Activation/maturation marker expression in bystander DCs. Representative flow cytometry profile and cumulative data of cells that were mock-
treated (red), challenged with IgG (light blue), LPS (green), HAdV5 (orange), or IC-HAdV5 (dark blue). A) The cell surface expression of CD86 (top panels),
CD83 (middle panels), and CD80 (bottom panels) were quantified 12 h post-stimulation. The profile of mock-treated cells is included in each panel as a
reference. The graphs to the right are the cumulative data from 5 donors and performed in duplicate. B) Representative flow cytometry profile and cumulative
data of total (intracellular and extracellular) CD86 and CD83 levels in bystander DCs incubated with DCs challenged with IgG, LPS, HAdV5, or IC-HAdV5 12
h post-stimulation (color-coded as in A). The mock-treated cells are included in each panel as references. The graphs to the right are the cumulative data from
4 donors and performed in duplicate. Error bars are ± SEM.  p< 0.05,  p< 0.01.
https://doi.org/10.1371/journal.ppat.1007127.g002
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Fig 3. Bystander DC cytokine transcription profile. A) Transcription profile of selected cytokines from bystander DCs at 12 h post-activation following exposure to
HAdV5- or IC-HAdV5-challenged direct DCs. The transcription profile of bystander DCs created by IgG-challenged direct DCs was used as the baseline. For the genes
in bold, primer sequences were designed in-house (n = 2 donors). B) Principal component analysis (PCA) of the changes in the 66 mRNAs included in the array. Three
principal components showed 61% (F1), 28% (F2), and 11% (F3) accordance. C) TNF, IFNβ, and CXCL10 mRNA levels in bystander DCs. Direct DCs were mock-, IgG-,
LPS-, HAdV5-, or IC-HAdV5-challenged. IC-HAdV5s were used at 20 x 103, 10 x 103, 5 x 103, or 1 x 103 physical particles/direct DC. Assays were carried out in 3
donors in at least duplicates. The fold increase is shown as mean ± SEM. See S1 Table for additional statistical analyses. D) Kinetics (3, 6, 18 h) of TNF (top panels) and
IFNβ (bottom panels) mRNA levels of THP-1-derived DC challenged with LPS, HAd5, IgG or IC-HAdV5 (left panels) or bystander DCs (using the milieu from the
direct DCs in the left panel) (right panels). Three independent assays in duplicate were performed. The fold increase is shown as the mean ± SEM. P values were derived
from one-way ANOVA with Dunnett’s test:  p< 0.01 and  p< 0.001.
https://doi.org/10.1371/journal.ppat.1007127.g003
IgG-complexed adenovirus and tolerance
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4D, second column). Similarly, when bystander DCs were generated using IC-HAdV5-chal-
lenged DCs, the level of the above five cytokines also increased. In addition, three chemokines
involved in immune cell recruitment (CCL15, CCL20, and CCL2) increased >3 fold. Consis-
tent with the transcriptome analyses, we did not find a notable dose-dependent effect on
bystander DCs when direct DCs were incubated with increasing IC-HAdV5 particles (Fig 4D,
middle columns).
Together, these data suggest that the release of pathogen-associated molecular patterns
(PAMPs), danger-associated molecular patterns (DAMPs), and/or the increased levels of cyto-
kines secreted by a greater number of DCs that do not undergo pyroptosis, are key factors in
bystander DC maturation. In addition, the environment created by IC-HAdV5 induces a
semi-mature cytokine secretion profile in bystander DCs.
Cytokines and pyroptosis-associated factors impact bystander DC
phenotype
To determine how cytokines and pyroptosis impact bystander DCs, we used a combination of
drugs and mutant HAdVs to selectively modify the environment created by IC-HAdV5-chal-
lenged DCs. To determine the impact of IL-1β, direct DCs were pre-treated with ZVAD, a
pan-caspase inhibitor that blocks caspase 1 auto-cleavage and pro-IL-1β processing. Impor-
tantly, ZVAD has no effect on TNF and canonical protein secretion (S4A Fig and reference
[14]). We found that blocking IL-1β production by direct DCs reduced bystander DC matura-
tion as demonstrated by their lower levels of CD86 and CD83 (Fig 5A and 5B). We then used
brefeldin A to block ER to Golgi-mediated cytokine secretion in direct DCs (see S4B Fig for
controls). Of note IL-1β release is not significantly affected by brefeldin A, (S4C Fig). In brefel-
din A-treated IC-HAdV5-challenged DCs the levels of CD83 and CD86 did not change
markedly (Fig 5C), while the bystander DCs responded with lower levels of CD83 and CD86
(Fig 5D).
Next, we generated ICs using AdL40Q [31], an HAdV5 capsid containing a mutated protein
VI that attenuates endosomolysis. While IC-AdL40Q poorly induces pyroptosis in direct DCs
[14], they secrete levels of TNF that are similar to IC-HAdV5-challenged DCs. Furthermore,
IFNβ and IL1β mRNA levels are lower [14]. We found notably lower levels of CD86 and CD83
on bystander DCs following stimulation with the response from IC-HAdV5 versus
IC-AdL40Q-challenged DCs. In addition, the reduced maturation/activation effects were only
modestly altered by increasing the IC-AdL40Q dose (Fig 5E). Together, these data demonstrate
a role for pyroptosis-associated factors in the maturation of bystander DCs.
We then compared cytokine mRNA levels in bystander DCs stimulated by HAdV5-,
IC-AdL40Q-, or IC-HAdV5-challenged DCs (Fig 5F and S5A–S5C Fig). Consistent with the
phenotype, the transcriptional responses of bystander DCs to both ICs were globally higher
than to HAdV5 alone. The bystander DC transcriptional response to IC-AdL40Q-challenged
DC milieu was generally lower than in IC-HAdV5-challenged DCs, and it was qualitatively
distinguishable as determined by PCA (Fig 5G).
We then assessed the effect of pyroptosis using IC-Ad2ts1. Ad2ts1 has a hyper-stable capsid
due to a mutation in protease that results in failure to process the capsid pre-protein [32,33].
Fig 4. Direct and bystander DC cytokine secretomes. A) Schema showing how DCs were activated with LPS, HAdV5, IgG, and
IC-HAdV5 and when the cell supernatants were harvested. B) Cytokine secretion from IgG-, HAdV5-, dose-dependent
IC-HAdV5-, and LPS-challenged DCs at 12 h. C) Cytokine secretion from IgG-, HAdV5-, dose-dependent IC-HAdV5-, and LPS-
challenged DCs at 12–21 h. D) Cytokine secretion from bystander DCs (the stimulus used to challenge the direct DCs is above
each column at 12–21 h). The color code shows relative increases compared to IgG-challenged-DCs (raw values in first column).
The assays were performed twice in duplicate with similar results.
https://doi.org/10.1371/journal.ppat.1007127.g004
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We previously showed that IC-Ad2ts1 poorly induces DC pyroptosis, likely because the HAdV
genome does not escape from the capsid and therefore does not nucleate AIM2 (see reference
[14] and S5D–S5F Fig for Ad2ts1 controls). Of note, TNF levels are comparable in DCs chal-
lenged with IC-Ad2ts1 or IC-HAdV5 [14]. Here, we found that IC-Ad2ts1-challenged DC
induced an increase of CD86 cell surface levels on bystander DCs (Fig 5H). Together, these
data demonstrate that cytokines, DAMP, and PAMPs play a role in the activation and semi-
maturation of bystander DCs.
Engagement of TLR4 on bystander DCs
To characterize how bystander DCs are activated, we focused on Toll-like receptor 4 (TLR4).
TLR4 is a multi-functional cell surface PRR that can directly or indirectly (by forming a com-
plex with MD-2, CD14, or other PRRs) be activated by extracellular viral components
(PAMPs) and, under inflammatory conditions, extracellular high-mobility group box 1 and
heat shock proteins (DAMPs) [34–36]. Of note, MD-2 acts as a co-receptor for recognition of
both exogenous and endogenous ligands [37–40]. While TLR4 does not bind to, or become
activated by, HAdV5 alone [41], TLR4 might be activated by PAMPs or DAMPs that interact
directly with the HAdV5 capsid. We therefore used TAK-242 to disrupt TLR4 signaling in
bystander DCs (see S6 Fig for TAK-242 control). As readouts, we used the upregulation of
TNF and IL1β mRNAs, and activation/maturation cell surface markers. When TLR4 signaling
was blocked in bystander DCs stimulated by the IC-HAdV5-challenged DC milieu, there was
a significant (p< 0.05) decrease in IL1β mRNA levels and 2-fold decrease of TNF mRNA (Fig
6A). CD83 and, to a lesser extent, CD86 levels were also reduced (Fig 6B). These data suggest
that bystander DCs use TLR4 to detect PAMPs and DAMPs released by IC-HAdV5-chal-
lenged DCs, leading to changes in bystander DC maturation.
Minimal loss of phagocytosis in bystander DCs is consistent with
tolerogenic profile
Immature DCs survey the extracellular environment by random phagocytosis. Once PRRs are
engaged, DC maturation is accompanied by decreased uptake of fluid phase molecules [42]. Of
note, a functional hallmark of tolerogenic DCs is their ability to retain some antigen uptake
properties. To address the functional maturation of IC-HAdV5-challenged DCs and bystander
DCs, we incubated cells with FITC-labeled dextran and quantified uptake by flow cytometry.
We found that phagocytosis was modestly decreased in direct DCs stimulated with HAdV5 or
LPS (Fig 7A). By contrast, IC-HAdV5-challenged DC phagocytosis was near background lev-
els, consistent with complete maturation (see S7 Fig for controls) [29]. While bystander DCs
had reduced phagocytosis when created by IC-HAdV5-challenged DCs, the bystander DCs
still took up 17-fold more FITC-dextran than background levels (Fig 7B). These functional
data are consistent with semi-mature, tolerogenic DC profile.
Fig 5. Impact of cytokines and pyroptosis-associated factors on bystander DC maturation. A & B) Shown are representative flow
cytometry profile and cumulative data of direct DCs pretreated with ZVAD using the approach described in S1 Fig. The cell surface levels of
CD86 and CD83 on bystander DCs was quantified by flow cytometry (n = 3 donors). C & D) Representative flow cytometry profile and
cumulative data of IC-HAdV5-challenged DCs treated with brefeldin A and the cell surface and intracellular levels of CD86 and CD83
quantified by flow cytometry in direct DCs and bystander DCs (n = 5 donors). E) Bystander DCs were incubated with milieu generated by
DC challenged with increasing doses of IC-AdL40Q (representative flow cytometry profiles and cumulative data of CD86 and CD83 levels)
(n = 3 donors). F) Bystander DC inflammatory cytokine mRNA levels were measured by RT-qPCR array following incubation with DC
challenged with HAdV5, IC-HAdV5 and IC-AdL40Q. The heat map denotes the fold change relative to DCs challenged by IgGs (n = 3
donors). G) PCA of the changes in the 66 mRNAs included in the array when including IC-AdL40Q. H) Bystander DCs were incubated with
milieu generated by DCs challenged with increasing doses of IC-Ad2ts1. Representative flow cytometry profiles and cumulative data of cell
surface level of CD86 (n = 2 donors).
https://doi.org/10.1371/journal.ppat.1007127.g005
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Fig 6. Impact of TLR4 engagement on cytokine transcription and activation and maturation markers in bystander DCs. Involvement
of TLR4 signaling in bystander DCs was assessed by A) IL1β and TNF mRNA levels in bystander DCs pre-treated with TAK-242, and then
IgG-complexed adenovirus and tolerance
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Bystander DCs recruit monocytes
While tolerogenic DCs can induce, recruit, and maintain Treg homeostasis, tolerogenic DCs
can also create a feedback loop to promote their own generation [43]. Because monocytes are
recruited to sites of inflammation [44,45], we compared the recruitment capabilities of direct
DCs and bystander DCs (see S8 Fig for setup and controls). Unexpectedly, we found that
IC-HAdV5-challenged DCs inhibited monocyte recruitment in an IC-HAdV5 dose-depen-
dent manner (Fig 8A & 8B). Of note, the inhibition was abrogated when the IC-HAdV5-chal-
lenged DCs were washed, suggesting that inhibitory factors were generated <3 h post-
IC-HAdV5 challenge (Fig 8B). To determine if pyroptosis-related factors (i.e. IL-1β, DAMPs
and PAMPs) are responsible for the inhibition of monocyte recruitment, we used ZVAD and
IC-AdL40Q to reduce pyroptosis. ZVAD, which prevents caspase 1 auto-activation, IL-1β matu-
ration, and GSDMD-associated pore formation, modestly increased monocyte recruitment
induced by IC-HAdV5-challenged DC (Fig 8C & 8D). In contrast to the IC-HAdV5-chal-
lenged DC response, the IC-AdL40Q-challenged DC response significantly (p< 0.05) increased
monocyte recruitment, in a dose-dependent manner (Fig 8E & 8F). These data suggest that
DC pyroptosis inhibits monocyte recruitment.
We then examined the ability of bystander DCs to recruit monocytes. In contrast to
IC-HAdV5-challenged DCs, bystander DCs promoted monocyte recruitment (Fig 8G). These
data are consistent with the bystander DC milieu containing more chemoattractants (Fig 5).
There was also a trend towards greater recruitment when higher IC-HAdV5 doses were used
to stimulate the direct DCs.
Once monocytes migrate into an inflammatory environment they acquire distinct phe-
notypic and functional profiles [46]. One phenotypic hallmark of monocyte differentia-
tion is CD14, which is high on monocytes and macrophages, but lower on DCs. We
therefore characterized migrating and static monocytes for CD14 and CD86 levels at 24
and 72 h (see schematic at the left of each panel in Fig 8H–8J for the times and location of
cells, and S8 Fig for controls). At 24 h the level of CD14 on monocytes that had migrated
into the bystander DCs environment did not change markedly, while CD86 levels were
lower (Fig 8H). At 72 h the recruited monocytes had two distinct populations based on
CD14 levels (Fig 8I). The decrease in CD14 levels suggested that they differentiated into
DCs, while the CD86 levels suggest the maintenance of an immature phenotype. In addi-
tion, monocytes recruited by bystander DCs had increased CD14 levels. By contrast,
CD86 levels decreased on monocytes in the upper chamber (bottom chamber containing
bystander DCs) (Fig 8J).
Together, these data demonstrate that DCs challenged with IC-HAdV5 inhibit monocyte
recruitment. Monocytes recruited to the bystander DC environment was abetted by pyroptosis
of the direct DCs. Recruited monocytes had reduced CD14 levels, possibly due the engagement
and internalization of TLR4/CD14 complexes. Monocyte-DC contact also appeared to favor
the increase in cell surface levels of activation/maturation markers. We concluded that the
dynamic environment created by bystander DCs is consistent with a feed-forward loop to fos-
ter tolerogenic DCs.
added to milieu of DCs challenged with LPS, IgG, HAdV5 and IC-HAdV5. Fold increase is represented as mean ± SEM (n = 3 donors, 
denotes p< 0.05) B) Representative flow cytometry profiles and cumulative data of CD86 and CD83 cell surface levels in bystander DCs.
DCs were mock-treated (red line), TAK-242 alone (with TAK-242 and without direct DCs, green line) challenged with IC-HAdV5 (dark
blue) or pretreated with TAK-242 and challenged with the milieu generated from IC-HAdV5-challenged DCs (violet line) (n = 3 donors, 
denotes p< 0.001).
https://doi.org/10.1371/journal.ppat.1007127.g006
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Fig 7. Fluid phase uptake by direct and bystander DCs. Fluid phase antigen uptake by direct and bystander DCs was quantified using FITC-labeled dextran and
flow cytometry. A) Representative flow cytometry profiles and cumulative data of direct DCs challenged with LPS, HAdV5, IgG, or IC-HAdV5 and B)
Representative flow cytometry profiles and cumulative data of bystander DCs with the corresponding direct DC milieu. Nonspecific binding of dextran to cells was
controlled by incubation at 4˚C (S7 Fig). MFI–median fluorescent index; n = 3 donors, in duplicate.
https://doi.org/10.1371/journal.ppat.1007127.g007
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Bystander DCs induce memory T-cell proliferation and naïve CD4 T cells
towards HAdV-specific Tregs
A functional characteristic of tolerogenic DCs is that they can take up and present antigens.
Therefore, we asked if some of the bystander DCs generated in our ex vivo model are capable
of inducing proliferation of HAdV5-specific memory T cells. We used IC-HAdV-challenged
DC to generate bystander DCs, which were then added to CFSE-labeled PBMCs. Seven days
post-incubation we found that CD3+/CFSElow cells harbored memory T cell markers
(CD45RO+/CD45RA-) (Fig 9A). These data are consistent with the potential of some of the
bystander DCs to maintain fluid phase uptake and subsequent presentation of HAdV5 anti-
gens to memory T cells.
In addition to antigen presentation, tolerogenic DCs can induce naïve CD4+ cells to
become Tregs. To address this functional characteristic, bystander DCs were generated and
incubated with autologous naïve CD4+/CD45RAhigh cells for 3 or 7 days. The T cells were then
assayed by multi-parametric flow cytometry for CD4, CD25, CD127 and FoxP3, markers that
are indicative of Tregs. While activated T cells transiently express FoxP3 (S9 Fig), the relatively
low-level does not result in acquisition of suppressor activity [27]. By contrast, stable and high
levels of FoxP3 can be used to identify bona fide Tregs. At day 3, naïve T cells expressed Treg
markers in all conditions (except mock-treated direct DCs) (Fig 9B). At day 7, the number
cells with Treg phenotype was near background following incubation in the milieu of mock-,
IgG-, or HAdV5-challenged direct DC (Fig 9C). By contrast, bystander DC created from
IC-HAdV-direct DCs had a significant (p< 0.05) increase in cells with a Treg profile. These
data demonstrate that bystander DCs can induce naïve CD4 into cells with a Treg phenotype,
further supporting our conclusion that they are tolerogenic DCs.
As shown in Fig 1D, healthy adults harbor CD25+ cells can inhibit HAdV-specific CD4+
cell proliferation. We therefore asked if the tolerogenic bystander DCs generated in our ex
vivo assay could induce the production of HAdV-specific Tregs. To address this question we
isolated PBMCs, CD14+ monocytes, and naïve CD4+ T cells from 3 donors that harbored anti-
HAdV memory T cells (see S10 Fig for flow chart). Briefly, monocytes were used to create
direct DCs that were incubated with IC-HAdV-C5. Bystander DCs were generated as previ-
ously described. VPD 450-labeled naïve CD4+ T cells were incubated with bystander DCs to
generate Tregs. VPD 450
low/CD4+/CD25+ cells (600 to 5,000 cells) were isolated by FACS and
mixed with CFSE-labeled PBMCs ± hexon peptides. We found that the ex vivo generated Tregs
from 3/3 donors reduced the proliferation of anti-HAdV T cells (CFSElow/CD4+) (Fig 9D).
These data demonstrate that HAdV-specific Tregs can be generated via bystander DCs.
Fig 8. Direct and bystander DC monocyte recruitment and their phenotype. A 5 μm-pore transwell system (see S8 Fig for details) was used for monocyte
migration assays. A) Representative FSC/SSC profiles of CFSE-labeled monocyte (blue) that migrated into the lower direct DC chamber; The numbers in
dark blue correspond to the percentage of CFSE-labeled monocytes. B) Cumulative data from monocyte migration at 24 h into the lower chamber containing
DCs challenged with HAdV5, IgGs or decreasing doses (20 x 103, 10 x 103 and 5 x103) of IC-HAdV5 and washed after 30 min post-challenge; data are
mean ± SEM, n = 4 donors; C) Representative FSC/SSC profiles of direct DCs (red) pretreated with ZVAD before activation with IC-HAdV5. The CFSE-
stained monocytes (blue) were added to the upper compartment and migration was quantified at 24 h; Numbers in dark blue correspond to the percentage of
CFSE-labeled monocytes. D) Cumulative data from assay in (C) n3 donors; E) Representative FSC/SSC profiles of DCs (red) challenged with decreasing
doses of IC-HAdV5 or IC- AdL40Q and CFSE-labeled monocyte (blue) recruitment at 24 h. The numbers in dark blue correspond to the percentage of CFSE-
labeled monocytes. F) Cumulative data from assay in (E) using DCs from3 donors; G) Bystander DCs activated for 12 h with milieu from DC challenged
with increasing concentration of IC-HAdV5. The bystander DCs were seeded in the lower chamber of a transwell and CFSE-labeled monocyte recruitment
was quantified by flow cytometry at 24 h (n4 donors). The numbers in dark blue correspond to the percentage of CFSE-labeled monocytes. H) Phenotypic
characterization of the monocytes (green cells seeded in the upper chamber) recruited by bystander DCs. DCs were challenged with increasing doses of
IC-HAdV5 (colored coded on top of each panel). The milieu from these direct DCs was used to generate bystander DCs. The bystander DCs were seeded in
the lower chamber of the transwell system and the monocytes that were recruited were characterized for their expression of CD14 and CD86 at 24 h, and I) at
72 h. J) Monocytes that did not migrate into the lower chamber were also characterized for the CD14 and CD86 levels. The data are representative flow
cytometry profiles of experiments carried out in5 donors. p values in B, D, and F were derived from t-tests:  p< 0.05,  p< 0.01, and  p< 0.001.
https://doi.org/10.1371/journal.ppat.1007127.g008
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Fig 9. Bystander DCs induce memory T cell proliferation and promote naïve CD4 cells towards Treg phenotype that inhibit proliferation of anti-HAdV
T cells. A) Bystander DCs, generated via IC-HAdV stimulation of direct DCs or mock-treated DCs, were incubated with CFSE-labeled PBMCs and
proliferation was quantified by flow cytometry. CD3+/CFSElow cells were screened for memory T cell profile (CD45RO vs. CD45RA). Bystander DCs,
generated using the media from DCs challenged with IgG, HAdV5, and IC-HAdV5, were incubated with 105 naive CD4+ T (ratio of 10:1 PBMC/ bystander
DC) cells isolated from the same donors. The percentage of Tregs (CD25
+/FoxP3high/CD127dim/CD4+ cells) varies between 1 to 5% of CD4+ cells in peripheral
blood. The number of Tregs in the CD4
+ cell population, ± bystander DCs, was quantified by analyzing 50,000 cells by flow cytometry. The results are
presented as percentage of increase of mock-treated cells at day 3 (B) or day 7 (C). D) Tregs generated by bystander DCs reduce the proliferation of memory
anti-HAdV CD4 T cells. Experiments were carried out in7 donors with similar results.  p< 0.05 vs. mock, HAdV5 and IgG.
https://doi.org/10.1371/journal.ppat.1007127.g009
IgG-complexed adenovirus and tolerance
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1007127 August 20, 2018 18 / 31
Discussion
HAdV infections lead to multifaceted, robust, long-lived cellular and humoral responses in
most young immunocompetent adults. Nonetheless, several HAdV types somehow circum-
vent immune surveillance to establish persistent infections. It is well documented that HAdV
neutralizing antibodies are type specific, while the anti-HAdV cellular response is cross-reac-
tive [1,3,8,47–49]. In addition, it is the anti-HAdV cellular response that protects us from reac-
tivation of persistent infections. The dichotomy between the two arms of the adaptive immune
response led us to address how anti-HAdV antibodies influence anti-HAdV T-cell responses.
In this study, we initially asked if healthy adults harbor HAdV-specific Tregs, which would be
indicative of a path towards HAdV persistence. We then explored how tolerogenic DCs and
HAdV-specific Tregs could be generated. We previously showed that IC-HAdV5s are internal-
ized by, and aggregate in, DCs [14]. Following protein VI-dependent endosomal escape of the
capsid, the viral genome is engaged by AIM2 in the cytoplasm. AIM2 nucleation induces ASC
(apoptosis-associated speck protein containing a caspase activation/recruitment domain)
aggregation, inflammasome formation, caspase 1 auto-activation, pro-IL-1β and GSDMD
cleavage, and GSDMD-mediated loss of cell membrane integrity. Here we demonstrate that
the pyroptotic environment induced by IC-HAdV5 plays a significant role the creation of tol-
erogenic bystander DCs. We further show that some of these bystander DCs can induce
HAdV-specific memory T cells to proliferate, and/or drive naïve CD4 cells towards a Treg phe-
notype. The Tregs generated in this ex vivo assay are capable of inhibiting the proliferation of
anti-HAdV T cells. We therefore propose that an antiviral humoral responses can, counterin-
tuitively, abet HAdV persistence.
Our assays using a human pathogen, naturally occurring human antibodies and primary
blood-derived human cells address one possible immune cell-based mechanisms of adenovirus
persistence. Yet, ex vivo results cannot unequivocally show causality. Host-pathogen-based
studies have often used mice to address questions underlying disease-immune relationships.
However, the impact of HAdVs on human and mouse DCs is notably different. Furthermore,
we are unaware of studies directing addressing the impact of murine adenovirus (MAV) on
murine DCs. In 1964, D. Ginder showed that a MAV can cause persistent infections for 10
weeks in outbred Swiss mice [50]. K. Spindler and colleagues then showed that MAV-1 infec-
tions persist for at least 55 weeks in outbred Swiss mice [51]. In addition, Spindler and col-
leagues demonstrated that in contrast to humans, mice that lack B cells are highly susceptible
to MAV-1 infection, while mice that lack T cells are not susceptible [52]. In light of our results,
the question could be raised as to whether anti-MAV-1 antibodies are needed to generate Tregs
to reduce the potential impact T-cell induced immunopathology [27]. To address this one
could use a single pre-injection of sera from MAV-1-challenged mice into B-cell deficient
mice and quantify disease progression.
Using nonhuman primates (NHPs) to address the dichotomy between the two arms of the
adaptive immune response to adenoviruses is likely a more informative option, but use of
NHPs entails unique challenges when it comes to pre-existing exposure to their own set of ade-
noviruses. Nonetheless, Miller and colleagues showed that rhesus macaques harboring a neu-
tralizing antibody response against a HAdV5 host-range mutant, and then re-challenged with
the same virus, respond with a significant increase in circulating Tregs [53]. These in vivo obser-
vations, which hinge on pre-existing HAdV5 neutralizing antibodies, are consistent with our
proposed mechanism. One also needs to take into account the dynamic, recurrent exposure to
multiple HAdV types during childhood and adolescence. Although our study focused on
HAdV5, a relatively common species C HAdV, we believe that recurrent exposure provides
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numerous opportunities for the formation of IC-HAdVs, from multiple HAdV types, and the
impetus to form cross-reactive HAdV Tregs.
Our data also complement the mechanism for HAdV persistence described by Hearing and
colleagues [6]. Using human cell lines, they showed that IFN-α and IFN-γ production block
HAdV5 replication via an E2F/Rb transcriptional repression of its E1A immediate early gene
[54]. The E1A gene product is essential for activating expression of the other early genes and
reprogramming the cell into a state that allows virus propagation. Of note, type 1 IFN secretion
is significant from IC-HAdV5-challenged DCs and may allow HAdVs (including those that
are covered with non-neutralizing Abs) to be taken up by neighboring cells to establish persis-
tent infections.
Mechanisms by which DCs promote tolerance include induction of Tregs, the inhibition of
memory T-cell responses, T-cell anergy, and clonal deletion [24–26]. The semi-mature pheno-
type of tolerogenic DCs provide insufficient stimulatory signals and drive naïve T cells to dif-
ferentiate into Tregs rather than effector T cells [55]. The global anti-viral response by DCs acts
via a combinatorial cytokine code to direct the response of neighboring immune cells. The
cytokine profile produced by the IC-HAdV5-challenged DCs and bystander DCs is notewor-
thy, particularly in the context of the combination and dose that influences activation of other
immune cells. Recently, a biochemical and functional chemokine interactome study suggested
that several chemokines form heterodimers that have unique functions in certain conditions
[56]. Based on these interactome data, we plotted the possible combinations that could influ-
ence the direct and bystander DCs in our assays (S11 Fig). What impact these heterodimers
could have on HAdV persistence will require future study, in particular because we did not
find notable levels of TGFβ secreted by direct or bystander DCs. More than other cytokine
families, the IL-1 family may be primordial because it is tightly linked to IC-HAdV-induced
DC pyroptosis. Indeed, the intracellular domain of the IL-1R1 shares similar signaling func-
tion properties with TLRs. In general, IL-1β release from monocytes is tightly controlled; less
than 20% of the total pro-IL-1β precursor is processed and released. IL-1β also increases the
expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule−1, which,
together with the chemokines, promote the infiltration of cells from the circulation into the
extravascular space and then into inflamed tissues [57]. While circulating monocytes do not
constitutively express IL1β mRNA, adhesion to surfaces during diapedesis induces the synthe-
sis of large amounts that are assembled into large polyribosomes primed for translation [58].
At least two aspects of the IC-HAdV-induced DC immune response that remain unknown
are the impact of neutrophils and the phenotype/function of recruited monocytes. Neutrophils
are pertinent because they can secrete/release proteinase 3 (PR3), elastase, cathepsin-G, chy-
mase, chymotrypsin, and meprin α or β, which can process extracellular pro-IL-1β into its
active form [59,60]. In addition, IC-HAdVs activate neutrophils (L-selectin shedding) via Fc
receptors and complement receptor 1 interactions [61]. Moreover, neutrophils are a major
source for anti-microbial peptides (e.g., defensins and LL-37) and proteins (e.g. lactoferrin) for
which a pro- or anti-viral roles in HAdV infection has been proposed [62]. With respect to the
phenotype/function of recruited monocytes, Ly6Chi monocytes [63], which suppress T-cell
proliferation during HAdV-induced inflammation [64], may also impact the creation of
HAdV antigen-presenting tolerogenic DCs and HAdV-specific Tregs.
The dynamic equilibrium between recurrent HAdV infections and IC-HAdV formation,
DC maturation/pyroptosis, recruitment and generation of bystander DC, and Tregs produc-
tion/activation, likely starts in childhood and develops nonlinearly over decades. While it is
hard to argue that the generation of persistent infections is not beneficial to the pathogen, it is
possible that the sustained anti-HAdV cellular and humoral responses partially shield a healthy
host from infections by other pathogens (e.g. hepatitis C virus [65]) or the related immune-
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induced tissue damage [66]. Avoiding chronic tissue damage is particularly important because,
as mentioned previously, HAdVs infect the eye, respiratory and gastrointestinal tracts. How-
ever, in a T-cell compromised host IC-HAdV-induced pyroptosis of FcγR+ cells (neutrophils,
monocytes, macrophages, DCs) may also prime the host for HAdV-disseminated disease.
In summary, our findings suggest a mechanism by which humoral immunity to HAdV fos-
ters tolerance. Understanding this complex virus-host interplay may enable us to identify high




Blood samples from anonymous donors (~120 from the Etablissement Franc¸ais du sang,
Montpellier, France, and 58 from Lausanne University Hospital/CHUV) were used during
this study. All donors provided written informed consent.
Cells and culture conditions
DCs were generated from freshly isolated CD14+ monocytes in the presence of 50 ng/ml gran-
ulocyte-macrophage colony-stimulating factor (GM-CSF) and 20 ng/ml interleukin-4 (IL-4)
(PeproTech, Neuilly sur Seine, France) [3]. DC stimulations were performed 6 days post-isola-
tion of monocytes. THP-1 cells purchased from ATCC (TIB-202) were cultured in RPMI 1640
medium supplemented with 10% fetal bovine serum (FBS). Similar to DCs, THP-1 cells were
differentiated into DCs using 50 ng/ml GM-CSF and 20 ng/ml IL-4 for 6 days.
HAdV vectors & hexon peptides
Adβgal is a ΔE1/E3 HAdV5 vector harboring a lacZ expression cassette [69]. AdL40Q is an
HAdV5-based vector with a leucine to glutamine mutation of an amino acid in protein VI that
decreases its membrane lytic activity [31]. Alexa555- and Alexa488-HAdV5 were generated
from Adβgal by using an Alexa555 or Alexa488 Protein Labeling Kit (Life Technologies, Ville-
bon-sur-Yvette, France) as previously described [70]. Ad2ts1 harbors a mutation in protease
and results in several unprocessed capsid proteins and a hyper-stable capsid [71]. All HAdV
viruses/vectors were produced in 293 or 911 cells and purified by double banding on CsCl
density gradients as previously describe [14]. Vector purity typically reaches >99%. HAdV
concentrations (physical particles/ml) were determined as previously described [72]. The
hexon peptide pool (PepTivator AdV5 hexon, Miltenyi) is overlapping sequences of the
HAdV5 hexon protein.
Antibodies
Anti-human CD4-PE (cat 300508) was from BioLegend. Anti-human CD83-FITC (cat
556910), anti-human HLA-ABC-PE (cat 555553), anti-human HLA-DR-PE (cat 555812), anti-
human CD80-FITC (cat 557226), anti-human CD86-APC (cat 555660), anti-human CD25-PE
(cat 555432), anti-human CD127-FITC (cat 561697), anti-human CD4-PE-Cy7 (BD) (cat
348809), anti-TNF-PE-Cy7 (cat 557647), anti-human IL-2-PE (cat 559334), anti-human CD3-
APC-H7 (cat 560176), anti-human CD4-CF594 (cat 5562281), anti-human CD4-PB (pacific
blue), anti-human CD8-BV605 (cat 564116), anti-human CD8-PerCP-Cy5.5 (cat 341050),
anti-human IFN-γ–AF700 (cat 557995), anti-human CD35-PE-Cy7 (cat 557741), anti-human
IL-10 (cat 554707) were from Becton Dickinson, Pharmigen. Anti-human Foxp3-APC (cat
17-4776-41) was from eBioscience. Anti-human CD14-PE (cat A07764) was from Beckman
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Coulter. Anti-human CD45RO-APC/Cy7 (cat 304227), anti-human CD45RA-PE (cat
304205), anti-human CD3-APC (cat 300411), and anti-human CD40-APC (cat 313008) were
from BioLegend). Anti-human IL-10-BV421(cat 501421), anti-human CD45RA-BV711 (cat
304137), anti-human CD127-BV711 (cat 351327) from Biolegend, anti-human CD45RO-ECD
(cat IM2712) (BC), anti-human FoxP3-PE (cat 12-4777-42), from eBiosciences.
Immune complex formation and DC stimulations
DCs (4 x 105 in 400 μl of complete medium) were incubated with HAdV5 or IC-HAdV5 (or
IC) (2 x 104 physical particles (pp)/cell, unless otherwise indicated) for the indicated times.
IC-HAdV5s were generated by mixing the virus (8 x 109 physical particles) with 2.5 μl of IVIg
(human IgG pooled from 1,000 to 50,000 donors/batch) (Baxter SAS, Guyancourt, France) for
15 min at room temperature. IVIg is used in patients with primary or acquired immunodefi-
ciency as well as autoimmune diseases. Z-VAD-FMK 20 μM (ZVAD) was added 2 h before
stimulation. Brefeldin A was used at 3 μg/ml after 6 h stimulation or for the same time with
stimulation.
Bystander DC stimulation
DCs (1.5 x 106 in 1.5 ml of full media) were incubated ± LPS 100 ng/ml, HAdV5, and IgG in
the lower compartment of the well (12 mm diameter polyester membranes with 0.4 μm pores;
(Corning, Bagneaux-sur-Loing, France). After 6 h incubation, fresh immature DCs (6 x 105 in
600 μl of media) were added to the upper compartment and are referred to as bystander DCs.
TAK-242 was added to DCs 1 h pre-challenge.
Quantification of mRNA
Expression levels of cytokine and chemokine genes were evaluated using RT-qPCR assays.
Total RNA was isolated from cells using the high pure RNA isolation Kit (Roche, Berlin, Ger-
many) with a DNase I treatment during the purification and subsequent elution in 50 μl of
RNase-free water (Qiagen, IN, USA). Reverse transcription was performed with the super-
script first-strand synthesis system (Invitrogen) using 10 μl of total RNA and random hexam-
ers. The cDNA samples were diluted 1:20 in water and analyzed in triplicate using a
LightCycler 480 (Roche, Meylan, France). SYBR green PCR conditions were as follows: 95˚C
for 5 min and 45 cycles of 95˚C for 15 s, 65˚C or 70˚C for 15 s, and 72˚C for 15 s using
GAPDH as a standard. See S2 Table for primers sequencers. Relative gene expression levels of
each respective gene were calculated using the threshold cycle (2-ΔΔCT) method and normal-
ized to GAPDH mRNA levels.
RT2 Profiler PCR array
Expression levels of cytokine and chemokine mRNAs were analyzed using PCR array assays.
Total RNA was isolated from cells using the High Pure RNA isolation Kit (Roche, Berlin, Ger-
many) with a DNase I treatment during the purification and elution in 50 μl of RNase-free
water (Qiagen). Reverse transcription was performed with the RT2 First strand Kit (Qiagen,
Courtaboeuf, France), and the cDNA samples were analyzed in duplicate using a RT2 Profiler
TM PCR array (Qiagen). SYBR green PCR conditions were 95˚C for 10 min and 40 cycles of
95˚C for 15 s, and 60˚C for 1 min using 84 human inflammatory and receptor genes. The
potential mRNAs were chosen and then confirmed by RT-qPCR.
The genes that contributed in each axis in the PCA were as follows: F1 = CCL1, 2, 4, 5, 7 13,
15, 17, 20, 22, CSF1, CX3CL1,CXCL 1 to 3, 5, 8 to 11, FASLG, IFNG, IL10RA, IL10RB, IL15,
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IL1a, IL1b, IL7, NAMPT, TNFSF4, 10, 11, 13, 13B, and VEGFA. F2 = AIMP1, C5, CCL1, 2, 13,
17, 23, CRR1, 2, 3, 4, 5, CSF1, CX3CR1,CXCR2, IL10RA, I10RB, IL15, LTA, LTB, MIF, SPP1,
TNF, TNFSF4, 10, 11, 13, and 13B. F3 = CCL17, 23, CCR5,CX3CR1, IL10RA, IL5, IL9, MIF, and
OSM.
Co-stimulatory protein levels
Surface levels of CD83, MHCII, CD80, CD40, and CD86 were assessed by flow cytometry. Cell
membrane integrity was assessed by collecting cells via centrifugation at 800x g; the cell pellets
were then resuspended in PBS containing 10% FBS, propidium iodide (PI) (Sigma-Aldrich,
Missouri, USA), or 7-aminoactinomycin D (7AAD) (Becton-Dickinson, New Jersey, USA).
The cell suspension was incubated for the indicated times and analyzed using a FacsCalibur
flow cytometer (Becton-Dickinson) and FlowJo software.
Intracellular staining
Surface and intracellular levels of CD83 and CD86 (total protein) were stained with a BD Cyto-
fix/Cytoperm Fixation/Permeabilization Kit, and then measured by flow cytometry. To assess
cell membrane integrity, the cells were collected and centrifuged at a speed of 800x g; the cell
pellets were then resuspended in PBS, 10% FBS, PI (Sigma), or 7AAD and analyzed on a Facs-
Calibur flow cytometer (Becton-Dickinson) and FlowJo software.
Monocyte migration assay
Monocyte migration was evaluated using a 5.0 μm-diameter pore transwell system (Corning,
Bagneaux-sur-Loing, France). Monocytes (2 x 105 in 200 μl of full media) were added into
inserts and DCs or DCs (7.5 x 105 in 750 μl of full media) and ± LPS (100 ng/ml), HAdV5,
HAd555, or IgG in the lower wells. Monocytes were stained by carboxy-fluorescein diacetate-
succinimidyl ester (CFSE) (Molecular Probes, Eugene, OR, USA) (CellTrace CFSE Cell Prolif-
eration Kit). DCs incubated for 30 min with HAd555 or HAdV5 and IgG in the lower chamber
were or were not washed in medium before adding the stained CFSE monocytes. After 3, 6,
and 24 h incubation at 37˚C, the cells in the upper and lower compartment were detected
quantified using a FacsCalibur flow cytometer (Becton-Dickinson) and FlowJo software.
Cytokine secretion: ELISA and Luminex assays
Supernatant from the cells were collected and cytokine secretion was measured by ELISA and
Luminex assays. The secretion of TNF and IL-1β was quantified by ELISA using an OptEIA
human TNF ELISA Kit (Becton Dickinson) and human IL-1β/IL-1F2 DuoSet ELISA (R&D
Systems, Lille, France) following the manufacturer’s instructions. Additionally, 22 other cyto-
kines and chemokines were detected by Luminex using a Bio-plex pro human chemokine,
cytokine kit (Bio-Rad, Marnes-La-Coquette, France) following the manufacturer’s
instructions.
Depletion of CD25+ from PBMCs
PBMCs were isolated using standard gradient separation techniques. Half were CD25+-
depleted, using anti-CD25 in a human CD4+CD25+CD127dim/- Regulatory T Cell Isolation Kit
II and MACS separation system.
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CFSE and VPD 450 labeling
PBMCs were washed and suspended in PBS for labeling with CFSE or Violet Proliferation Dye
450 (VPD 450) (BD Horizon, Le Pont de Claix, France) at a final concentration of 2.5 μM or
1 μM, respectively, for 3 min at room temperature. Labeling was terminated by the addition of
fetal calf serum (FCS) (40% of total volume).
PBMC activation assays
PBMCs ± CD25+ were stained with CFSE and cultivated in 96-well U-bottom plates; (cell con-
centration 1 x 106/ml and a final volume of 200 μl; PBMC CD25+/ PBMC CD25- ratio 1:10).
HAdV5 hexon peptides (PepTivator, Miltenyi, Paris, France) were added at 0.3 nmol. On days
3 and 5 the cells were split and IL-2 was added (final concentration 100 U/ml). Cells were ana-
lyzed on a FACS Canto II using FlowJo software.
Treg generation
Naïve CD4+ T cell were isolated using naïve CD4+ T Cell Isolation Kit II and MACS separation
system. DCs indirectly activated for 12 h with LPS, HAdV5, IC-HAdV5 and IgG, and then
were co-cultured with CD4+ naïve T cells labeled VPD450 (with ratio bystander DCs/ T cells is
3:1) in RPMI 1640 supplemented with 10% FCS and IL-2 (Proleukin 18 x 106 IU, CA, USA)
(100 U/ml) for 3 or 7 days. Recombinant IL-2 was added on day 3 and day 5. CD25, CD127,
and FoxP3 levels were quantified by flow cytometry using FACS Canto II.
Statistical analyses
All experiments were performed at least in duplicate a minimum of three independent times,
and the results are expressed as mean ± SEM unless otherwise stated. The statistical analyses
were performed using the Student’s t-test unless otherwise stated. A p value< 0.05 is denoted
as significant. Statistical analyses of the global cytokine profiles (pie chart) were performed by
partial permutation tests using the SPICE software.
Supporting information
S1 Fig. Transwell assay setup and controls. A) We used transwell inserts with 0.4 um filter to
generate direct and bystander DCs. Direct DCs (1.5 x106 cells unless mentioned otherwise)
were incubated with the stimulus (e.g. LPS, HAdV5, mutant virus, ± IVIg ± drugs) in lower
compartment for 6 h. Fresh DCs (6 x 105) were added to the upper compartment.
B) To determine if HAdV5 particles (2 x 104 pp/ml) added to the lower chamber diffused to
the upper compartment and impact the bystander DCs, we quantified (by qPCR) HAdV5
genomes in the supernatant of each compartment. 1.6 x 1010 pp of HAdV5 pp were used in
the control medium. These data demonstrate that 10,000-fold fewer particles could be found
in the upper chamber.
C) Quantification of HAdV5 genomes associated with bystander DCs as measured by qPCR
(n3). DNA from mock-treated samples was extracted and virus/cell was normalized to
GAPDH copy number. The quantity of HAdV5 genomes/cell was normalized by lacZ (trans-
gene in the vector) vs. GAPDH copy number. While direct DCs take up ~600 pp/cell [14], we
found that 1 in 10 bystander DC contains a single HAdV5 genome.
D) The 7AAD+ bystander and direct DCs (i.e. DCs with compromised plasma membrane
integrity) in each condition were quantified by flow cytometry. The assays were carried out in
4 donors (mean ± SEM. These results demonstrate that bystander DCs do not show loss of cell
membrane integrity. p values were derived using Student’s t-test (B & C) or one-way ANOVA
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with Dunnett’s post-tests (D).  p< 0.05,  p< 0.01 and  p< 0.001.
(TIF)
S2 Fig. Maturation/activation markers on bystander DCs. Bystander DCs were generated
using milieu from DCs challenged with IgG, LPS, HAdV5, or IC-HAdV5. The color code is as
in Fig 2. A) The data are representative flow cytometry profiles of CD40 and MHC II surface
expression. A modest increase was noted in each case. B) In a dose-dependent assay (20,000,
5,000, or 1,000 pp/cell) CD86 cell surface levels were quantified detected by flow cytometry.
The data are representative flow cytometry profiles. Assays were carried out in 4 donors with
similar results. C) PCR array profiles from bystander DCs exposed to the milieu generated by
DCs challenged by HAdV5, IC-HAdV5, and IC-AdL40Q. The 66 cytokine mRNAs that gave
unique qPCR peaks in our hands. D) IL1β, IL12p40,CLL3 and IL6 mRNA levels in bystander
THP1 DCs assayed in a dose-dependent (20,000, 10,000, 5,000, or 1,000 pp/direct DC)
response. Data are mean ± SEM with 3 independent experiments. p values were derived from
one-way ANOVA with Dunnett’s test.  p< 0.05,  p< 0.01 and  p< 0.001.
(TIF)
S3 Fig. Bystander and direct DC cytokine mRNA levels as a function of time and dose. We
extended the mRNA array results by quantifying dose-dependent responses of a handful of
mRNA levels by RT-qPCR. Because DCs derived from monocytes from random blood bank
donors can have widely different levels of mRNAs, we compared mRNA levels in THP-
1-derived DCs to provide a standardized view of the changes. THP-1 cells were differentiated
into DCs for 6 days, then directly and indirectly activated. A) CCL3, IL1β, and IL6 mRNA lev-
els in DCs challenged with LPS, IgG, HAdV5 and IC-HAdV5 (left hand column), and
bystander DCs (right hand column) incubated in the respective direct DC milieu were quanti-
fied at 3, 6, and 18 h post-incubation. B) Changes in TNF, IL1β, IFNβ, IL6, and CCL3 mRNA
levels in direct (left hand column)
TNF: IC 2 x 104 vs. 104 ns; 104 vs. 5 x 103 ns; 5 x 103 vs. x 103 ; IL1β IC 2 x 104 vs. 104 ns; 104
vs. 5 x 103 ns; 5 x 103 vs. 103 ns; IC 2 x 104 vs. 103 , IC 104 vs. 103 ;
IFNβ: IC 2 x 104 vs. 104 ns; 104 vs. 5 x 103 ns; 5 x 103 vs. 103 ns, IC 2 x 104 vs. 103 ; IL6: IC 2 x
104 vs. 104 ns; 104 vs. 5 x 103 ; 5 x 103 vs. 1 x 103 ns;
CCL3: IC 2 x 104 vs. 1 x 104 ns; 1 x 104 vs. 5 x 103 ; 5 x 103 vs. 103 ns)
Bystander DC (right hand column) dose-dependent assay (2 x 104, 104, 5 x 103, or 103 pp/cell)
by RT-qPCR
TNF: IC 2 x 104 vs. 104 ns; 104 vs. 5 x 103 ns; 5 x 103 vs. 1 k ns, IC 2 x 104 vs. 103 , IC 104 vs.
103 ;
IL1β: IC20 k vs. 104 ns; 104 vs. 5 x 103 ns; 5 x 103 vs. 103 ns;
IFNβ: IC 20 k vs. 104 ns; 104 vs. 5 x 103 ns; 5 x 103 vs. 103 ;
IL6: IC 2 x 104 vs. 104 ns; 104 vs. 5 x 103 ns; 5 x 103 vs. 103 ns, 104 vs. 5 x 103 ;
CCL3: IC 2 x 104 vs. 104 ns; 104 vs. 5 x 103 ; 5 x 103 vs. 103 ).
As in “A” controls included IgG and HAdV5.
Three independent experiments were carried out. Data are mean ± SEM. p values were derived
using Student’s t-tests.  p< 0.05,  p< 0.01 and  p< 0.001.
(TIF)
S4 Fig. Controls for ZVAD and brefeldin A assays. A) TNF and IL-1β secretion in response
to ZVAD treatment (2 h before challenge) of DCs challenged with LPS, IgG, HAdV5, and
IC-HAdV5.
B) DCs were simultaneously treated with brefeldin A and challenged with LPS, IgG, HAdV5,
and IC-HAdV5. TNF secretion was quantified at 18 h.
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C) DCs were simultaneously treated with brefeldin A and challenged with LPS, IgG, HAdV5,
and IC-HAdV5. IL-1β secretion was quantified at 18 h. Data are mean ± SEM, p values were
derived from Student’s t-tests, n 3 donors.  p< 0.001.
(TIF)
S5 Fig. Controls for IC-AdL40Q and IC-Ad2ts1. A) DCs challenged with LPS, IgG, HAdV5,
AdL40Q and increasing concentrations of IC-HAdV5 and IC-AdL40Q were analyzed for loss of
membrane integrity (7AAD+ cells), IL-1β and TNF secretion.
B) Cell surface levels of the maturation/activation markers CD86 and CD83 following direct
DCs challenged with IgG, AdL40Q, IC-AdL40Q, HAdV5, and IC-HAdV5.
C) bystander DC IL1β and IFNβ mRNA levels quantified by RT-qPCR assay. Experiments
were carried out in3 donors. p values were derived from Student’s t-tests. , ,  denote p
values of< 0.05, < 0.01, < 0.001, respectively.
DCs were challenged with LPS, IgG, HAdV5, IC-HAdV5, Ad2ts1, and IC-Ad2ts1 and
screened for D) time-dependent (6 to 48 h) TNF secretion; and E) time-dependent (6 to 48 h)
loss of membrane integrity using propidium iodide (PI) incorporation; or
F) DCs were challenged with LPS, IgG, HAdV5, IC-HAdV5, Ad2ts1, and IC-Ad2ts1 and then
used to generate bystander DCs in which the IL1β mRNA levels were quantified by RT-qPCR
assay following dose-dependent stimulation (20 x 103, 10 x 103, or 5 x 103 pp/cell) of the direct
DCs.
Experiments were carried out in 3 donors and in duplicate. P values were derived from Stu-
dent’s t-tests.  p< 0.01.
(TIF)
S6 Fig. TAK-242 controls. Bystander DCs were treated with TAK-242 for 1 h before adding
them to the DCs challenged with LPS, IgG, HAdV5, or IC-HAdV5. TNF secretion was quanti-
fied in direct DCs in the lower compartment (n = 3 donors). p values were derived from Stu-
dent’s t-tests.  p< 0.0001.
(TIF)
S7 Fig. Controls for fluid phase uptake assay. Nonspecific binding of dextran to A) direct
DCs and B) bystander DCs was controlled by incubating DC (post-stimulation) with FITC-
labeled dextran at 4˚C. Direct DCs were challenged with IgG, LPS, HAdV5, or IC-HAdV5.
The cells were then incubated with FITC-labeled dextran and analyzed by flow cytometry. The
data are representative flow cytometry profiles with experiments performed using cells from in
3 donors and in duplicate.
(TIF)
S8 Fig. Controls for monocyte recruitment. A) A 5-micron-pore membrane transwell system
was used for monocyte migration assays. The timing and stimuli are indicated in the schemat-
ics. Round green cells are CFSE-labeled monocytes. B) These data shown percentage of mono-
cyte in the upper chamber that potentially interact with HAdV or IC-HAdV5. C) To address
this possibility, we covalently linked Alex555 to the HAdV5 capsid (HAdV5-Alexa555 [29]) to
identify cells associated with HAdV5 or IC-HAdV5. CFSE-labeled monocytes were then
assayed by flow cytometry for loss of membrane integrity (7AAD+ cells) and the presence of
HAdV5-Alexa555 at 6 and 24 h. These data demonstrate that ICs do not go through the pore
to interact with monocytes in the upper chamber. D) CD14 expression levels on monocytes
recruited towards bystander DCs that were created with the milieu from DCs challenged with
IgG, LPS or HAdV5 at 24 h. E) CD14 and CD86 levels on monocytes recruited to bystander
DCs that were created with the milieu from DCs challenged with IgG, LPS or HAdV5 at 72 h.
F) CD14 and CD86 expression levels on monocytes that remained in the upper compartment
IgG-complexed adenovirus and tolerance
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1007127 August 20, 2018 26 / 31
at 72 h. The lower compartment contained bystander DCs that were created with the milieu
from DCs challenged with IgG, LPS or HAdV5. The data are representative flow cytometry
profiles with assays carried out in 4 donors.  p< 0.05,  p< 0.01 and  p< 0.001.
(TIF)
S9 Fig. Bystander DCs, generated using the media from DCs challenged with IgG, HAdV5,
and IC-HAdV5, were incubated with naive CD4+ T cells isolated from the same donors.
Three days post-incubation we gated on CD127dim cells to identify CD25+/FoxP3high cells. The
data are representative flow cytometry profiles with assays carried out in 7 donors.
(TIF)
S10 Fig. Flow chart demonstrating the cells and process used for the Treg assays.
(TIF)
S11 Fig. Potential cytokine heterodimer formation/interactions. Potential cytokine hetero-
dimers are based on von Hundelshausen et al. [56] interactome data and the response gener-
ated by direct and bystander DCs.
(TIF)
S1 Table. Statistical analyses of bystander DC cytokine transcription profile.
(DOCX)
S2 Table. In-house designed primer sequences.
(DOCX)
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